http://dx.doi.org/10.1155/2013/759476">
 

Document Type

Journal Article

Department/Unit

School of Chinese Medicine

Title

Xiaoqinglong granules as add-on therapy for asthma: Latent class analysis of symptom predictors of response

Language

English

Abstract

Xiaoqinglong granules (XQLG) has been shown to be an effective therapy in asthma animal models. We reviewed the literature and conducted this study to assess the impact of XQLG as an add-on therapy to treatment with fluticasone/salmeterol (seretide) in adult patients with mild-to-moderate, persistent asthma. A total of 178 patients were randomly assigned to receive XQLG and seretide or seretide plus placebo for 90 days. Asthma control was assessed by asthma control test (ACT), symptoms scores, FEV and PEF. Baseline patient-reported Chinese medicine (CM)-specific symptoms were analyzed to determine whether the symptoms may be possible indicators of treatment response by conducting latent class analysis (LCA). There was no statistically significant difference in ACT score between two groups. In the subset of 70 patients with symptoms defined by CM criteria, XQLG add-on therapy was found to significantly increase the levels of asthma control according to global initiative for asthma (GINA) guidelines (P = 0.0329). There was no significant difference in another subset of 100 patients with relatively low levels of the above-mentioned symptoms (P = 0.1291). Results of LCA suggest that patients with the six typical symptoms defined in CM may benefit from XQLG. © 2013 Qinglin Zha et al.

Publication Date

2013

Source Publication Title

Evidence-Based Complementary and Alternative Medicine

Volume

2013

Start Page

759476-1

End Page

759476-10

Publisher

Hindawi Publishing Corporation

ISSN (print)

1741427X

ISSN (electronic)

17414288

This document is currently not available here.

Share

COinS